Abstract: GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer
Published: 2023 American Society of Clinical Oncology (ASCO)
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
Published: Frontiers in Oncology
Poster Presentation: GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies
Published: 2023 Society of Gynecologic Oncology Annual Meeting on Women's Cancer
Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malignancies
Published: The Journal of Precision Medicine
Abstract: GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies
Published: 2022 Early Detection of Cancer Conference
Aiming for the Sweet Spot: Glyco-Immune Checkpoints and gd T Cells in Targeted Immunotherapy
Published: Frontiers in Immunology